Literature DB >> 9826427

Cloning and expression of cDNA for a human Sia alpha 2,3Gal beta 1, 4GlcNA:alpha 2,8-sialyltransferase (hST8Sia III).

Y C Lee1, Y J Kim, K Y Lee, K S Kim, B U Kim, H N Kim, C H Kim, S I Do.   

Abstract

The cDNA encoding human Sia-alpha2,3-Gal-beta1,4-GlcNAc-R:alpha2, 8-sialyltransferase, hST8Sia III, was isolated by screening of a human brain cDNA library with polymerase chain reaction-amplified DNA probe generated from the sequence of mouse ST8Sia III (mST8Sia III) and by 5' rapid amplification of cDNA ends of mRNA isolated from human brain tissues. Comparative analysis of the predicted protein-coding region between our cloned hST8Sia III and mST8Sia III showed 92 and 96% identities in the nucleotide and the amino acid sequence, respectively. The soluble hST8Sia III protein expressed in COS-7 showed an extremely high catalytic activity of transferring sialic acid through alpha2,8-linkage to intact fetuin glycoprotein, whereas the transferring activity was completely undetectable toward either alpha2,6-sialylated glycoprotein or desialylated glycoprotein acceptors. Northern analysis of hST8Sia III showed that the transcript corresponding to 11 kb was expressed in both human fetal and adult brain, while the expression of the 5.5-kb transcript was restricted to fetal liver, indicating that the expression of hST8Sia III is developmentally and tissue-specifically regulated. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9826427     DOI: 10.1006/abbi.1998.0909

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  8 in total

Review 1.  Sialyltransferases in cancer.

Authors:  F Dall'Olio; M Chiricolo
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

2.  Molecular cloning and expression of a human hST8Sia VI (alpha2,8-sialyltransferase) responsible for the synthesis of the diSia motif on O-glycosylproteins.

Authors:  Mélanie Teintenier-Lelièvre; Sylvain Julien; Sylvie Juliant; Yann Guerardel; Martine Duonor-Cérutti; Philippe Delannoy; Anne Harduin-Lepers
Journal:  Biochem J       Date:  2005-12-15       Impact factor: 3.857

3.  Structure of human ST8SiaIII sialyltransferase provides insight into cell-surface polysialylation.

Authors:  Gesa Volkers; Liam J Worrall; David H Kwan; Ching-Ching Yu; Lars Baumann; Emilie Lameignere; Gregory A Wasney; Nichollas E Scott; Warren Wakarchuk; Leonard J Foster; Stephen G Withers; Natalie C J Strynadka
Journal:  Nat Struct Mol Biol       Date:  2015-07-20       Impact factor: 15.369

4.  Developmental regulation of oligosialylation in zebrafish.

Authors:  Lan-Yi Chang; Anne Harduin-Lepers; Ken Kitajima; Chihiro Sato; Chang-Jen Huang; Kay-Hooi Khoo; Yann Guérardel
Journal:  Glycoconj J       Date:  2008-08-14       Impact factor: 2.916

Review 5.  Cloning and transcriptional regulation of genes responsible for synthesis of gangliosides.

Authors:  Guichao Zeng; Robert K Yu
Journal:  Curr Drug Targets       Date:  2008-04       Impact factor: 3.465

6.  Functional roles of ST8SIA3-mediated sialylation of striatal dopamine D2 and adenosine A2A receptors.

Authors:  Chien-Yu Lin; Hsing-Lin Lai; Hui-Mei Chen; Jian-Jing Siew; Cheng-Te Hsiao; Hua-Chien Chang; Kuo-Shiang Liao; Shih-Chieh Tsai; Chung-Yi Wu; Ken Kitajima; Chihiro Sato; Kay-Hooi Khoo; Yijuang Chern
Journal:  Transl Psychiatry       Date:  2019-08-27       Impact factor: 6.222

Review 7.  Polysialic Acid in the Immune System.

Authors:  Tania M Villanueva-Cabello; Lya D Gutiérrez-Valenzuela; Roberta Salinas-Marín; Delia V López-Guerrero; Iván Martínez-Duncker
Journal:  Front Immunol       Date:  2022-02-11       Impact factor: 7.561

8.  Vertebrate Alpha2,8-Sialyltransferases (ST8Sia): A Teleost Perspective.

Authors:  Marzia Tindara Venuto; Mathieu Decloquement; Joan Martorell Ribera; Maxence Noel; Alexander Rebl; Virginie Cogez; Daniel Petit; Sebastian Peter Galuska; Anne Harduin-Lepers
Journal:  Int J Mol Sci       Date:  2020-01-14       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.